CN Patent
CN112851643A — 嘧啶苯甲酰胺化合物的盐酸盐及其用途
Assigned to Sunshine Lake Pharma Co Ltd · Expires 2021-05-28 · 5y expired
What this patent protects
本发明涉及嘧啶苯甲酰胺化合物的盐酸盐及其用途。本发明还涉及包含所述盐酸盐的药物组合物,以及所述盐酸盐或所述药物组合物在制备用于治疗和预防中枢神经系统功能障碍的药物中的用途。
USPTO Abstract
本发明涉及嘧啶苯甲酰胺化合物的盐酸盐及其用途。本发明还涉及包含所述盐酸盐的药物组合物,以及所述盐酸盐或所述药物组合物在制备用于治疗和预防中枢神经系统功能障碍的药物中的用途。
Drugs covered by this patent
- Akynzeo (NETUPITANT) · Helsinn Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.